1. Home
  2. SER vs APYX Comparison

SER vs APYX Comparison

Compare SER & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • APYX
  • Stock Information
  • Founded
  • SER 2017
  • APYX 1982
  • Country
  • SER United States
  • APYX United States
  • Employees
  • SER N/A
  • APYX N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • APYX Medical/Dental Instruments
  • Sector
  • SER Health Care
  • APYX Health Care
  • Exchange
  • SER Nasdaq
  • APYX Nasdaq
  • Market Cap
  • SER 56.5M
  • APYX 66.5M
  • IPO Year
  • SER 2018
  • APYX 1987
  • Fundamental
  • Price
  • SER $5.80
  • APYX $2.24
  • Analyst Decision
  • SER Strong Buy
  • APYX Hold
  • Analyst Count
  • SER 1
  • APYX 2
  • Target Price
  • SER $11.00
  • APYX N/A
  • AVG Volume (30 Days)
  • SER 16.6K
  • APYX 74.2K
  • Earning Date
  • SER 08-08-2025
  • APYX 08-07-2025
  • Dividend Yield
  • SER N/A
  • APYX N/A
  • EPS Growth
  • SER N/A
  • APYX N/A
  • EPS
  • SER N/A
  • APYX N/A
  • Revenue
  • SER $51,000.00
  • APYX $47,288,000.00
  • Revenue This Year
  • SER N/A
  • APYX $2.25
  • Revenue Next Year
  • SER N/A
  • APYX $6.76
  • P/E Ratio
  • SER N/A
  • APYX N/A
  • Revenue Growth
  • SER N/A
  • APYX N/A
  • 52 Week Low
  • SER $3.81
  • APYX $0.76
  • 52 Week High
  • SER $11.57
  • APYX $2.30
  • Technical
  • Relative Strength Index (RSI)
  • SER 57.53
  • APYX 63.27
  • Support Level
  • SER $5.50
  • APYX $1.84
  • Resistance Level
  • SER $6.29
  • APYX $2.27
  • Average True Range (ATR)
  • SER 0.52
  • APYX 0.22
  • MACD
  • SER 0.03
  • APYX 0.03
  • Stochastic Oscillator
  • SER 74.44
  • APYX 90.85

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Share on Social Networks: